Wnt agonist 1

Wnt agonist 1

Catalog Number:
L002371406APE
Mfr. No.:
APE-B6059
Price:
$175
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway [1].
          The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation [1].
          Wnt agonist 1 is a cell-permeable Wnt signaling pathway agonist. Wnt agonist 1 induced b-catenin- and TCF-dependent transcriptional activity in a dose-dependent way with EC50 of 0.7 μM. In Xenopus embryos, treatment with Wnt agonist 1 (10 μM) from developmental stage 10.5 to stage 40 resulted in substantial head defects, such as diminished heads and complete loss of eyes, and reduced eyes and heads. This phenotype is similar to that which results from Wnt over-expression in head specification during early embryonic development.

      • Properties
        • Categories
          agonist of Wnt signaling pathway
          Alternative Name
          BML-284; (Z)-1-(benzo[d][1,3]dioxol-5-yl)-N-(2-imino-6-(3-methoxyphenyl)-2,3-dihydropyrimidin-4(1H)-ylidene)methanamine hydrochloride
          CAS Number
          853220-52-7
          Molecular Formula
          C19H19ClN4O3
          Molecular Weight
          386.83
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥38.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
          Storage
          Store at -20°C
          SMILES
          COC1=CC=CC(C(NC2=N)=C/C(N2)=N/CC3=CC4=C(OCO4)C=C3)=C1.Cl

          * For Research Use Only

      • Reference
        • 1. Wenwen Liu, Yang Zhou, et al. "Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis." Clin Transl Med. 2021 Sep;11(9):e517. PMID:34586745
          2. Yang JM, Huang HM, et al. "LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway."Toxicology. 2018 Sep 8;410:65-72. PMID:30205152

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.